MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma

Hasanov, E; Jonasch, E

Jonasch, E (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021; 30 (5): 495